Envisage report cover

Pediatrics Vaccines Market: COVID-19 Impact and Global Analysis Forecast to 2028

Published Date: May 2021

No. of Pages: 207

Status: Upcoming

Report Code: EMR100216

Vaccination is an injection of antigenic material which helps develop an individual’s immunity system and make the human body resistant to a specific infection or chronic disease. Vaccination has helped towards aversion of death toll of all, adults and animals, especially children, thus nurturing them with controlled exposure to germs and infections and lead a better and healthier life ahead and pass it on to other generation. This belief has led to tremendous increase in the market of pediatric vaccination across the globe over certain period of time. In addition, vaccines help make one immune to serious diseases without getting sick at the first place and to reduce the severity of disease at another. Vaccines are generally targeted on two main market segments- pediatric and adult. Pediatric vaccines are frequently employed for the proper and efficient immunization of newborns and children below 18 years of age against several infections such as chicken pox, small pox, polio, measles, HPV, tetanus, hepatitis, meningococcal diseases, diphtheria, influenza diseases and pneumococcal diseases among others.

Increase in interest from both non-government and government organization in form of funding associated with the development of vaccines is one of the key factors driving the overall global pediatric vaccine market over the estimation period. Moreover, growth in cutting-edge technological advancement such as therapeutic and adjuvant vaccines is further stimulating the growth of the global pediatric vaccines market. In addition, soared investments by various existing and new players in the market along with key manufacturers of pediatric vaccines is leading to the growth prospect in the ever emerging market. Apart from it, growing interest of organizations as well as government bodies on the immunization schedule, childhood immunization programs prescribed by doctors for the adolescents, rising awareness programs and campaigns led by WHO, UNICEF and other healthcare organizations are further projected to enhance the market for Pediatric vaccination in global market.

The market for pediatric vaccine can be classified globally based on type, disease type and region. Based on type, the global market can be divided into inactivated, live, toxic, subunit and recombinant vector vaccines. Based on disease type, the global pediatric vaccines market can be segmented into measles, polio, pertussis, hepatitis A, hepatitis B, varicella, diphtheria, influenza, mumps, tetanus, rubella and others. Based on geography, the global pediatric vaccines market can be said to be focused on North America, Latin America, Europe, Middle East & Africa and Asia Pacific. The tremendously increased demand in Asia-Pacific is expected to be the major driving force for the growth of the global pediatrics vaccines system market. China is expected to be the largest shareholder for the market and the leader in overall demand for pediatrics vaccines owing to increasing industrial production over the last few years. The market for pediatric vaccine in other developing countries such as Poland, New Zealand, Brazil, Argentina, Russia, Indonesia and India is also expected to grow swiftly throughout the forecast period.
Major players in the global pediatrics vaccines system market include Sanofi, Genentech Inc., Novartis AG., GlaxoSmithKline, Amgen Inc., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Abbott Laboratories, Eli Lilly and Company, Actelion Pharmaceuticals Ltd among others. These players are focusing on key market strategies such as mergers and acquisitions, cooperating with local players in order to withstand in the ever competitive market and to grow their market reach as well as fortify their goodwill in the global market.
The market for pediatric vaccine can be globally segmented

By Type:
• Into inactivated
• Live
• Toxic
• Subunit
• Recombinant vector vaccines

By Disease Type:
• Measles
• Polio
• Pertussis
• Hepatitis A
• Hepatitis B
• Varicella
• Diphtheria
• Influenza
• Mumps
• Tetanus
• Rubella
• Others

By Region:
• North America
• Latin America
• Europe
• Middle East & Africa
• Asia Pacific

The Leading Key Players in Pediatrics Vaccines Market

Genentech Inc.
Novartis AG.
Amgen Inc.
AstraZeneca Plc
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Shire Pharmaceuticals Group Plc
Merck & Co. Inc
Abbott Laboratories
Eli Lilly
Actelion Pharmaceuticals Ltd